Takeshi Kotake

767 total citations
59 papers, 461 citations indexed

About

Takeshi Kotake is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Takeshi Kotake has authored 59 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Takeshi Kotake's work include Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (7 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Takeshi Kotake is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (7 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Takeshi Kotake collaborates with scholars based in Japan, China and Saudi Arabia. Takeshi Kotake's co-authors include Masakazu Toi, Mitsutaka Takada, Kazuo Komamura, Shiro Kamakura, Akihito Tsuji, Yukimasa Hatachi, Hiroshi Amemiya, Shogo Ozawa, Hironaga Satake and Hideto Jinno and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Takeshi Kotake

55 papers receiving 451 citations

Peers

Countries citing papers authored by Takeshi Kotake

Since Specialization

Citations

This map shows the geographic impact of Takeshi Kotake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Kotake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Kotake more than expected).

Fields of papers citing papers by Takeshi Kotake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Kotake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Kotake. The network helps show where Takeshi Kotake may publish in the future.

Co-authorship network of co-authors of Takeshi Kotake

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Kotake. A scholar is included among the top collaborators of Takeshi Kotake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Kotake. Takeshi Kotake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a broad range of two-colour ozone indicator 2024 ·Heliyon ·(unknown), Shunji Ishiwata, (unknown), Yuko Okamoto, Masaki Yoshioka, Tomomi Inoue, Takeshi Kotake	1
2	Applicability of on-site disinfection of personal protective equipment by ozone gas 2023 ·Heliyon ·Shunji Ishiwata, (unknown), Tomoe Sakashita, (unknown), Tomomi Inoue, Takeshi Kotake	3
3	Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis 2023 ·Breast Cancer Research and Treatment ·(unknown), Kosuke Kawaguchi, K. Kawanishi, (unknown), (unknown), Tatsuki R. Kataoka, (unknown), Shunsaku Nakagawa, Atsushi Yonezawa, Masahiro Takada, Masahiro Kawashima, Nobuko Kawaguchi‐Sakita, Takeshi Kotake, Eiji Suzuki, Hanako Shimizu, Masae Torii, Satoshi Morita, Hiroshi Ishiguro, Masakazu Toi	2
4	Early diagnosis and bevacizumab combined with chemotherapy improved pulmonary tumor thrombotic microangiopathy with lung adenocarcinoma: A case report 2022 ·SHILAP Revista de lepidopterología ·Takeshi Kotake, (unknown), (unknown), (unknown), Takaki Sakurai, Jumpei Takeshita, (unknown), (unknown), (unknown), Kazuhiro Yanagihara	1
5	FOLFIRINOX as First-line Chemotherapy in Japanese Patients Suffering from Metastatic Pancreatic Cancer (KOBE FOLFIRINOX Study) 2022 ·Cancer Diagnosis & Prognosis ·Yukimasa Hatachi, (unknown), Takeshi Kotake, Hironaga Satake, (unknown), Hisateru Yasui, Akihito Tsuji	1
6	Phase Ib/II study of nivolumab combined with palliative radiation therapy for bone metastasis in patients with HER2-negative metastatic breast cancer 2022 ·Scientific Reports ·Masahiro Takada, Michio Yoshimura, Takeshi Kotake, Kosuke Kawaguchi, Ryuji Uozumi, Masako Kataoka, Hiroaki Kato, Hiroshi Yoshibayashi, Hirofumi Suwa, Wakako Tsuji, Hiroyasu Yamashiro, Eiji Suzuki, Masae Torii, Yosuke Yamada, Tatsuki R. Kataoka, Hiroshi Ishiguro, Satoshi Morita, Masakazu Toi	13
7	Downregulated ATP6V1B1 expression acidifies the intracellular environment of cancer cells leading to resistance to antibody-dependent cellular cytotoxicity 2020 ·Cancer Immunology Immunotherapy ·(unknown), Eiji Suzuki, Masakazu Hattori, (unknown), Tatsuki R. Kataoka, Masahiro Hirata, (unknown), Takeshi Kotake, (unknown), (unknown), Tomoharu Sugie, Masakazu Toi	16
8	Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients 2018 ·Breast Cancer ·Eiji Suzuki, Masahiro Sugimoto, Kosuke Kawaguchi, (unknown), Ryuji Uozumi, (unknown), (unknown), (unknown), Takeshi Kotake, Satoshi Morita, Masakazu Toi	17
9	Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type RAS gene: the JACCRO CC-14 study 2018 ·International Journal of Clinical Oncology ·Hironaga Satake, Akihito Tsuji, Masato Nakamura, Masaaki Ogawa, Takeshi Kotake, Yukimasa Hatachi, Hisateru Yasui, Akinori Takagane, (unknown), Kumi Nakamura, (unknown), Masahiro Takeuchi, Masashi Fujii	11
10	First-line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I study 2017 ·Molecular and Clinical Oncology ·Hironaga Satake, Hisateru Yasui, Takeshi Kotake, (unknown), Yukimasa Hatachi, Masahito Kotaka, Takeshi Kato, Akihito Tsuji	5
11	Phase I Study of Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin for Locally Advanced Gastric Cancer 2017 ·Anticancer Research ·Hironaga Satake, Masato Kondo, (unknown), Takeshi Kotake, (unknown), Takatsugu Ogata, Yukimasa Hatachi, Hisateru Yasui, Akira Miki, Yukihiro Imai, (unknown), Kenta Murotani, Masahito Kotaka, Takeshi Kato, Satoshi Kaihara, Akihito Tsuji	3
12	Novel polyacetylene derivatives and their inhibitory activities on acetylcholinesterase obtained from Panax ginseng roots 2016 ·Journal of Natural Medicines ·Kazuya Murata, (unknown), (unknown), Keiichi Samukawa, Toshihiko Ishizaka, Takeshi Kotake, Hideaki Matsuda	22
13	The combination of HLA-B15:01 and DRB115:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer 2016 ·Cancer Chemotherapy and Pharmacology ·(unknown), Masanori Toyoda, (unknown), Yoshinori Imamura, Naoko Chayahara, Naomi Kiyota, Toru Mukohara, Takeshi Kotake, Akihito Tsuji, Kosuke Saito, Yoshiro Saito, Hironobu Minami	15
14	Application of ozone gas for decontamination of nucleoside anticancer drugs 2016 ·Journal of Pharmaceutical Health Care and Sciences ·Ayumi Tsukamoto, Shunji Ishiwata, (unknown), (unknown), (unknown), Tomomi Inoue, Takeshi Kotake	8
15	Drug interactions between tacrolimus and phenytoin in Japanese heart transplant recipients: 2 case reports 2007 ·International Journal of Clinical Pharmacology and Therapeutics ·Keita Wada, Mitsutaka Takada, Tetsuya Ueda, Hiroki Ochi, Takeshi Kotake, (unknown), Akihisa Hanatani, (unknown)	12
16	Serum amiodarone and desethylamiodarone concentrations following nasogastric versus oral administration 2006 ·Journal of Clinical Pharmacy and Therapeutics ·Takeshi Kotake, Mitsutaka Takada, (unknown), Kazuo Komamura, Shiro Kamakura, (unknown)	19
17	Functional analysis of four naturally occurring variants of human constitutive androstane receptor 2005 ·Molecular Genetics and Metabolism ·Shinobu Ikeda, Kouichi Kurose, Hideto Jinno, Kimie Sai, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Takeshi Kotake, (unknown), Shiro Kamakura	35
18	Appropriate dosing regimen of allopurinol in Japanese patients1 2005 ·Journal of Clinical Pharmacy and Therapeutics ·Mitsutaka Takada, Hiroshi Okada, Takeshi Kotake, (unknown), Makoto Saito, M. Nakai, (unknown), (unknown)	15
19	Genetic Polymorphisms of UGT1A6 in a Japanese Population 2005 ·Drug Metabolism and Pharmacokinetics ·Mayumi Saeki, Yoshiro Saito, Hideto Jinno, Kimie Sai, Nahoko Kaniwa, Shogo Ozawa, Kazuo Komamura, Takeshi Kotake, (unknown), Shiro Kamakura, Masafumi Kitakaze, Hitonobu Tomoike, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo, Naoyuki Kamatani, Jun‐ichi Sawada	28
20	[Parathyroid tumors--on primary hyperparathyroidism in Japan]. 1972 ·PubMed ·Takao Sonoda, Manabu Takeuchi, Kenji Kinoshita, Takeshi Kotake, S Nagano	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact